Furthermore, we used free fatty acid receptor FFAR2 (a crucial SCFA signaling molecule) agonist to investigate the role of gut microbiota metabolites, such as SCFAs, in the treatment of cancer cachexia, with comparisons to PCPs. This evidence concerns the gene FFAR2 and cancer.